Literature DB >> 27259369

CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.

Natasha M Rogers1, Zheng J Zhang2, Jiao-Jing Wang2, Angus W Thomson3, Jeffrey S Isenberg4.   

Abstract

Defects in renal tubular epithelial cell repair contribute to renal ischemia reperfusion injury, cause acute kidney damage, and promote chronic renal disease. The matricellular protein thrombospondin-1 and its receptor CD47 are involved in experimental renal ischemia reperfusion injury, although the role of this interaction in renal recovery is unknown. We found upregulation of self-renewal genes (transcription factors Oct4, Sox2, Klf4 and cMyc) in the kidney of CD47(-/-) mice after ischemia reperfusion injury. Wild-type animals had minimal self-renewal gene expression, both before and after injury. Suggestive of cell autonomy, CD47(-/-) renal tubular epithelial cells were found to increase expression of the self-renewal genes. This correlated with enhanced proliferative capacity compared with cells from wild-type mice. Exogenous thrombospondin-1 inhibited self-renewal gene expression in renal tubular epithelial cells from wild-type but not CD47(-/-) mice, and this was associated with decreased proliferation. Treatment of renal tubular epithelial cells with a CD47 blocking antibody or CD47-targeting small interfering RNA increased expression of some self-renewal transcription factors and promoted cell proliferation. In a syngeneic kidney transplant model, treatment with a CD47 blocking antibody increased self-renewal transcription factor expression, decreased tissue damage, and improved renal function compared with that in control mice. Thus, thrombospondin-1 via CD47 inhibits renal tubular epithelial cell recovery after ischemia reperfusion injury through inhibition of proliferation/self-renewal.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD47; OSKM; ischemia-reperfusion injury; kidney; self-renewal; thrombospondin-1

Mesh:

Substances:

Year:  2016        PMID: 27259369     DOI: 10.1016/j.kint.2016.03.034

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  26 in total

Review 1.  The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Pediatr Nephrol       Date:  2018-11-03       Impact factor: 3.714

2.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

3.  Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death.

Authors:  Min Xu; Xuanchuan Wang; Babak Banan; Danielle L Chirumbole; Sandra Garcia-Aroz; Aparna Balakrishnan; Deepak K Nayak; Zhengyan Zhang; Jianluo Jia; Gundumi A Upadhya; Joseph P Gaut; Ronald Hiebsch; Pamela T Manning; Ningying Wu; Yiing Lin; William C Chapman
Journal:  Am J Transplant       Date:  2017-12-02       Impact factor: 8.086

Review 4.  Matricellular protein thrombospondin-1 in pulmonary hypertension: multiple pathways to disease.

Authors:  Natasha M Rogers; Kedar Ghimire; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

5.  Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.

Authors:  Sohel M Julovi; Barkha Sanganeria; Nikita Minhas; Kedar Ghimire; Brian Nankivell; Natasha M Rogers
Journal:  Lab Invest       Date:  2020-05-04       Impact factor: 5.662

6.  Rictor deficiency in dendritic cells exacerbates acute kidney injury.

Authors:  Helong Dai; Alicia R Watson; Daniel Fantus; Longkai Peng; Angus W Thomson; Natasha M Rogers
Journal:  Kidney Int       Date:  2018-09-04       Impact factor: 10.612

7.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

8.  TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.

Authors:  Natasha M Rogers; Maryam Sharifi-Sanjani; Mingyi Yao; Kedar Ghimire; Raquel Bienes-Martinez; Stephanie M Mutchler; Heather E Knupp; Jeffrey Baust; Enrico M Novelli; Mark Ross; Claudette St Croix; Johannes C Kutten; Caitlin A Czajka; John C Sembrat; Mauricio Rojas; David Labrousse-Arias; Timothy N Bachman; Rebecca R Vanderpool; Brian S Zuckerbraun; Hunter C Champion; Ana L Mora; Adam C Straub; Richard A Bilonick; Maria J Calzada; Jeffrey S Isenberg
Journal:  Cardiovasc Res       Date:  2016-10-13       Impact factor: 10.787

9.  Kidney-intrinsic factors determine the severity of ischemia/reperfusion injury in a mouse model of delayed graft function.

Authors:  Longhui Qiu; Xingqiang Lai; Jiao-Jing Wang; Xin Yi Yeap; Shulin Han; Feibo Zheng; Charlie Lin; Zhuoli Zhang; Daniele Procissi; Deyu Fang; Lin Li; Edward B Thorp; Michael M Abecassis; Yashpal S Kanwar; Zheng J Zhang
Journal:  Kidney Int       Date:  2020-08-18       Impact factor: 10.612

Review 10.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.